Analyst Ratings for Viridian Therapeutic (VRDN) [Buys]
VRDN Rating Summary
VRDN Price Target Summary
- Highest: $51.00 (Credit Suisse)
- Lowest: $20.00 (B.Riley)
- Average: $35.89
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$35.89 (+158.2%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$35.89 (+158.2%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/14/2023 | BTIG | Julian Harrison | New Coverage | Buy (N/A) |
46.00 (N/A) |
26.54 (13.90) |
-47.63% | Details |
| 6/14/2023 | Credit Suisse | Judah Frommer | New Coverage | Outperform (N/A) |
51.00 (N/A) |
25.50 (13.90) |
-45.49% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
